Phase 2a study shows promising antidepressant effects
Category: News
Promising trial results support marketing authorisation application
Successful phase 1 study highlights potential of roginolisib
Promising results set stage for European marketing authorization
New cell therapy shows potential in treating advanced blood disorder
New findings presented at international SCWD conference
Trial results lead to new treatment option for lung cancer
promising pre-clinical data on preventing cytokine release syndrome
Phase 3 trial indicates significant efficacy and safety for children and adolescents